| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $385 | +2466.7% | +156.7% |
| R&D Expense | -$1K | -101.2% | -102.8% |
| SG&A Expense | $9.9M | — | +3577.9% |
| Operating Income | -$10.6M | -538.7% | -2293.3% |
| Interest Expense | $3K | — | — |
| Pre-tax Income | -$10.5M | -776.0% | -2265.7% |
| Net Income | -$10.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $44.1M | — | — |
| Current Assets | $44.8M | — | — |
| Total Assets | $51.7M | +1883.6% | — |
| Current Liabilities | $883K | +13.0% | +278.0% |
| Total Liabilities | $883K | +13.0% | +278.0% |
| Stockholders' Equity | $50.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.0M | — | — |
| Capital Expenditures | $835 | — | — |
| Investing Cash Flow | -$6.8M | — | — |
| Financing Cash Flow | $51.1M | — | — |
| Free Cash Flow | -$5.0M | — | — |
| -2265.7% |
| EPS (Basic) | -$0.77 | -541.7% | -1183.3% |
| EPS (Diluted) | -$0.77 | -541.7% | -1183.3% |
| +2685.3% |
| — |